APOE and Schnyder corneal dystrophy: In agreement with the FINGER 2.0 Model, the PENSA Study suggests that combining a MLI with the dietary compound EGCG may be associated with cognitive improvements in APOE-ɛ4 carriers with SCD, with indications of long-term benefits.